Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.5M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
96.7K
-
Shares change
-
+39.5K
-
Total reported value, excl. options
-
$5.36M
-
Value change
-
+$2.19M
-
Number of buys
-
2
-
Price
-
$55.50
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q4 2023
2 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q4 2023.
Arcellx, Inc. - COMMON STOCK (ACLX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.7K shares
of 55.5M outstanding shares and own 0.17% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (4.54M shares), FMR LLC (4.38M shares), NEA Management Company, LLC (3.75M shares), Paradigm Biocapital Advisors LP (3.66M shares), SR ONE CAPITAL MANAGEMENT, LP (3.15M shares), BlackRock Inc. (3.02M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.44M shares), VANGUARD GROUP INC (2.06M shares), STATE STREET CORP (1.77M shares), and Cormorant Asset Management, LP (1.7M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.